News | December 10, 2023
Aptar Pharms opens new production facility at Taloja, Mumbai
New facility is part of Aptar Pharma’s global expansion program
New facility is part of Aptar Pharma’s global expansion program
The company is assessing the situation and simultaneously undertaking all the requisite action
The company has received Form 483 with three observations
The full transition of Viatris' biosimilars operations to Biocon Biologics in Europe represents another significant milestone
The company also organised sensitization workshops for its employees aimed at increasing awareness of challenges faced by hearing-impaired individuals
Both the India and GCC entities will be operated by separate dedicated management teams
The divestment is a part of Fortis' ongoing portfolio rationalization strategy
Expanded collaboration with Vanguard Renewables aims to significantly increase the productivity of US renewable natural gas generation
The company has raised US$4.5 million in funding for its AI operating system
European operations' revenue grew 58.4% to Rs 599.7 crore
Subscribe To Our Newsletter & Stay Updated
